Avammune Therapeutics
6 known investors
Find your way into Avammune Therapeutics
Sign up to see every warm intro you have to Avammune Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Avammune Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Avammune is a biotech company developing novel therapeutic modalities to address hard-to-treat cancers with distinct mechanisms of action. The company focuses on patient-centric oncology drug discovery, emphasizing improved compliance, ease of administration, and greater accessibility.
Founders & leadership
Investors · 6
How we know: funding news · press coverage · Not right? Tell us
How we know: Capital2B's portfolio page · Not right? Tell us
How we know: Redstart Labs's portfolio page · Not right? Tell us
How we know: Shastra VC's portfolio page · funding news · press coverage · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
Frequently asked questions
- What does Avammune Therapeutics do?
- Avammune is a biotech company developing novel therapeutic modalities to address hard-to-treat cancers with distinct mechanisms of action. The company focuses on patient-centric oncology drug discovery, emphasizing improved compliance, ease of administration, and greater accessibility.
- Who founded Avammune Therapeutics?
- Avammune Therapeutics was founded by Arun, Aditya, Srinivasan.
- Who are Avammune Therapeutics's investors?
- Avammune Therapeutics's investors include 1Crowd, Capital2B, Redstart Labs, Shastra VC, IvyCap Ventures, The Chennai Angels.



